The Proceedings of the American Thoracic Society 3:364-372 (2006)
© 2006 The American Thoracic Society
Role of Epithelial Cells in Idiopathic Pulmonary Fibrosis
From Innocent Targets to Serial Killers
Moisés Selman and
Annie Pardo
Dirección de Investigación, Instituto Nacional de Enfermedades Respiratorias, México City; and Facultad de Ciencias, Universidad Nacional Autónoma de México, México D.F., Mexico
Correspondence and requests for reprints should be addressed to Dr. Moisés Selman, Instituto Nacional de Enfermedades Respiratorias, Tlalpan 4502 CP 14080, México DF, México. E-mail: moiselman{at}salud.gob.mx
ABSTRACT
Idiopathic pulmonary fibrosis (IPF), a progressive and relentless lung scarring of unknown etiology, has been recognized as the most lethal interstitial lung disease. Despite the growing interest in IPF, the precise molecular mechanisms underlying the development of fibrosis and leading to the irreversible destruction of the lung are still unknown. Recently, it has been proposed that IPF, instead of being a chronic inflammatory disorder, results from multiple cycles of epithelial cell injury and activation. In turn, active alveolar epithelial cells provoke the migration, proliferation, and activation of mesenchymal cells with the formation of fibroblastic/myofibroblastic foci and the exaggerated accumulation of extracellular matrix, mirroring abnormal wound repair. In this article, some characteristics of the alveolar epithelium are briefly outlined, and the fibrogenic mechanisms specifically operated by active abnormal epithelial cells are examined.
Key Words: epithelial cells idiopathic pulmonary fibrosis lung fibrosis pathogenesis
This article has been cited by other articles:

|
 |

|
 |
 
K. Konishi, K. F. Gibson, K. O. Lindell, T. J. Richards, Y. Zhang, R. Dhir, M. Bisceglia, S. Gilbert, S. A. Yousem, J. W. Song, et al.
Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
July 15, 2009;
180(2):
167 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. D. Hardie, S. W. Glasser, and J. S. Hagood
Emerging Concepts in the Pathogenesis of Lung Fibrosis
Am. J. Pathol.,
July 1, 2009;
175(1):
3 - 16.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Adair, V. Stober, M. Sobhany, L. Zhuo, J. D. Roberts, M. Negishi, K. Kimata, and S. Garantziotis
Inter-{alpha}-trypsin Inhibitor Promotes Bronchial Epithelial Repair after Injury through Vitronectin Binding
J. Biol. Chem.,
June 19, 2009;
284(25):
16922 - 16930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. N. Shukla, J. L. Rose, R. Ray, K. L. Lathrop, A. Ray, and P. Ray
Hepatocyte Growth Factor Inhibits Epithelial to Myofibroblast Transition in Lung Cells via Smad7
Am. J. Respir. Cell Mol. Biol.,
June 1, 2009;
40(6):
643 - 653.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Oikonomou, A Thanasopoulou, A Tzouvelekis, V Harokopos, T Paparountas, I Nikitopoulou, W Witke, A Karameris, A Kotanidou, D Bouros, et al.
Gelsolin expression is necessary for the development of modelled pulmonary inflammation and fibrosis
Thorax,
June 1, 2009;
64(6):
467 - 475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. El-Chemaly, D. Malide, E. Zudaire, Y. Ikeda, B. A. Weinberg, G. Pacheco-Rodriguez, I. O. Rosas, M. Aparicio, P. Ren, S. D. MacDonald, et al.
Abnormal lymphangiogenesis in idiopathic pulmonary fibrosis with insights into cellular and molecular mechanisms
PNAS,
March 10, 2009;
106(10):
3958 - 3963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kaarteenaho-Wiik and Y. Soini
Claudin-1, -2, -3, -4, -5, and -7 in Usual Interstitial Pneumonia and Sarcoidosis
J. Histochem. Cytochem.,
March 1, 2009;
57(3):
187 - 195.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. F. Mercer, R. H. Johns, C. J. Scotton, M. A. Krupiczojc, M. Konigshoff, D. C. J. Howell, R. J. McAnulty, A. Das, A. J. Thorley, T. D. Tetley, et al.
Pulmonary Epithelium Is a Prominent Source of Proteinase-activated Receptor-1-inducible CCL2 in Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
March 1, 2009;
179(5):
414 - 425.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Cottin, N. Fabien, C. Khouatra, A. Moreira, and J-F. Cordier
Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema
Eur. Respir. J.,
January 1, 2009;
33(1):
219 - 221.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J Allan, J. Beattie, and D. J Flint
Epithelial injury induces an innate repair mechanism linked to cellular senescence and fibrosis involving IGF-binding protein-5
J. Endocrinol.,
November 1, 2008;
199(2):
155 - 164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Garantziotis, E. Zudaire, C. S. Trempus, J. W. Hollingsworth, D. Jiang, L. H. Lancaster, E. Richardson, L. Zhuo, F. Cuttitta, K. K. Brown, et al.
Serum Inter-{alpha}-Trypsin Inhibitor and Matrix Hyaluronan Promote Angiogenesis in Fibrotic Lung Injury
Am. J. Respir. Crit. Care Med.,
November 1, 2008;
178(9):
939 - 947.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Chen, J. K. McGuire, R. C. Hackman, K.-H. Kim, R. A. Black, K. Poindexter, W. Yan, P. Liu, A. J. Chen, W. C. Parks, et al.
Tissue Inhibitor of Metalloproteinase-1 Moderates Airway Re-Epithelialization by Regulating Matrilysin Activity
Am. J. Pathol.,
May 1, 2008;
172(5):
1256 - 1270.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Radisky and J. A. Przybylo
Matrix Metalloproteinase-induced Fibrosis and Malignancy in Breast and Lung
Proceedings of the ATS,
April 15, 2008;
5(3):
316 - 322.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Horan, S. Wood, V. Ona, D. J. Li, M. E. Lukashev, P. H. Weinreb, K. J. Simon, K. Hahm, N. E. Allaire, N. J. Rinaldi, et al.
Partial Inhibition of Integrin {alpha}v 6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
Am. J. Respir. Crit. Care Med.,
January 1, 2008;
177(1):
56 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Barrera, F. Mendoza, J. Zuniga, A. Estrada, A. C. Zamora, E. I. Melendro, R. Ramirez, A. Pardo, and M. Selman
Functional Diversity of T-Cell Subpopulations in Subacute and Chronic Hypersensitivity Pneumonitis
Am. J. Respir. Crit. Care Med.,
January 1, 2008;
177(1):
44 - 55.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tzouvelekis, V. Harokopos, T. Paparountas, N. Oikonomou, A. Chatziioannou, G. Vilaras, E. Tsiambas, A. Karameris, D. Bouros, and V. Aidinis
Comparative Expression Profiling in Pulmonary Fibrosis Suggests a Role of Hypoxia-inducible Factor-1{alpha} in Disease Pathogenesis
Am. J. Respir. Crit. Care Med.,
December 1, 2007;
176(11):
1108 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Haston, M. Begin, G. Dorion, and S. M. Cory
Distinct Loci Influence Radiation-Induced Alveolitis from Fibrosing Alveolitis in the Mouse
Cancer Res.,
November 15, 2007;
67(22):
10796 - 10803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. Maher, A. U. Wells, and G. J. Laurent
Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?
Eur. Respir. J.,
November 1, 2007;
30(5):
835 - 839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Hunninghake and M. I. Schwarz
State of the Art. Does Current Knowledge Explain the Pathogenesis of Idiopathic Pulmonary Fibrosis?: A Perspective
Proceedings of the ATS,
August 15, 2007;
4(5):
449 - 452.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Vyas-Read, P. W. Shaul, I. S. Yuhanna, and B. C. Willis
Nitric oxide attenuates epithelial-mesenchymal transition in alveolar epithelial cells
Am J Physiol Lung Cell Mol Physiol,
July 1, 2007;
293(1):
L212 - L221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Studer and N. Kaminski
Towards Systems Biology of Human Pulmonary Fibrosis
Proceedings of the ATS,
January 1, 2007;
4(1):
85 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 by the American Thoracic Society.
|
|
|